Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19 - JAMA Network

Retrieved on: 2024-05-24 16:25:36

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19 - JAMA Network. View article details on hiswai:

Excerpt

Pemivibart is the only long-acting monoclonal antibody available in the US for preexposure prophylaxis after the FDA revoked authorization of ...

Article found on: jamanetwork.com